Dr. Michael Whitfield shares why scleroderma research is entering a promising new era. As a Scleroderma Research Foundation funded investigator, Dr. Whitfield (of the Geisel School of Medicine at Dartmouth) is part...
Read More
Raynaud’s phenomenon is a common medical condition, and most people with Raynaud’s will not develop scleroderma. But, nearly 90% of those with scleroderma DO have Raynaud’s symptoms. For this reason,…
Amazon has announced that they are discontinuing AmazonSmile on February 20, 2023. To everyone who prioritized the SRF while you shopped, thank you. You’ve helped us accelerate the pace of…
Do you live with scleroderma and have digital ulcers? You’re invited to complete a survey launched the World Scleroderma Foundation ad hoc GI Committee—led by SRF-funded investigator Dr. Zsuzsanna McMahan,…
Calling all scleroderma advocates—February is Rare Disease Awareness Month and Raynaud’s Awareness Month! The SRF stands with the rare disease community because being rare does not mean being alone. And…
The first SRF eNews of 2023 is now online! Learn more about upcoming awareness campaigns in February, why one of our funded investigators thinks we're entering an exciting new era...
Read More
Amber was just nine years old when she was diagnosed with scleroderma in 1997. More than 20 years later, she looks back at her journey and how far she has...
Read More
Last weekend, Greg Cohen ran the Chevron Houston Marathon to raise funds for the Scleroderma Research Foundation—and set a half marathon personal record while doing it! 🏃♂️ While there, he...
Read More
UPDATE: The date for the forum has been changed to June 6, 2023. Save the date: The Annual SRF Patient Forum is back this year on June 1, 2023! "Collaborating...
Read More
As we start the new year, join us in welcoming the newest member of the team! Meet Kate Ceredona, our Director of Philanthropy. Kate is a development professional with over…
